A new Era of Personalized Medicine for Cystic Fibrosis – at Last!
The gene responsible for cystic fibrosis (CF) was discovered 25 years ago. This breakthrough has enabled a sophisticated understanding of how various mutations lead to specific alterations in the structure and function of the CF transmembrane regulator (CFTR) protein. Until recently, all therapies i...
Saved in:
| Main Authors: | Bradley S Quon, Pearce G Wilcox |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/2015/921712 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plasma sCD14 as a biomarker to predict pulmonary exacerbations in cystic fibrosis.
by: Bradley S Quon, et al.
Published: (2014-01-01) -
Optic Disc Swelling and Vision Loss in a Patient with Cystic Fibrosis and Diabetes
by: Ioulia Iosfina, et al.
Published: (2013-01-01) -
Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations.
by: Ashutosh Sharma, et al.
Published: (2017-01-01) -
A new era of cystic fibrosis therapy with CFTR modulators
by: Laura Gomes Boabaid de Barros, et al.
Published: (2025-01-01) -
Progress of personalized medicine of cystic fibrosis in the times of efficient CFTR modulators
by: Burkhard Tümmler, et al.
Published: (2025-05-01)